Is the minimally clinically important difference (MCID) fit for purpose? A planned study using the SAQ
J. Lanario (Plymouth, United Kingdom), R. Jones (Plymouth, United Kingdom), M. Hyland (Plymouth, United Kingdom), A. Menzies-Gow (London, United Kingdom), A. Mansur (Birmingham, United Kingdom), J. Dodd (Bristol, United Kingdom), S. Fowler (Manchester, United Kingdom), M. Patel (Plymouth, United Kingdom), G. Hayes (Plymouth, United Kingdom), M. Masoli (Exeter, United Kingdom)
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Session: Clinical parameters in severe asthma
Session type: E-poster session
Number: 2241
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Lanario (Plymouth, United Kingdom), R. Jones (Plymouth, United Kingdom), M. Hyland (Plymouth, United Kingdom), A. Menzies-Gow (London, United Kingdom), A. Mansur (Birmingham, United Kingdom), J. Dodd (Bristol, United Kingdom), S. Fowler (Manchester, United Kingdom), M. Patel (Plymouth, United Kingdom), G. Hayes (Plymouth, United Kingdom), M. Masoli (Exeter, United Kingdom). Is the minimally clinically important difference (MCID) fit for purpose? A planned study using the SAQ. 2241
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: